Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OD-PHOENIX for Osteochondral Lesion of Talus
NCT02736318Phase 2Terminated
- Sponsor
- TBF Génie Tissulaire
- Start
- Jan 2017
- Primary completion
- Sep 2021
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial in osteochondral lesion of the talus (OLT), sponsored by TBF Génie Tissulaire. Primary endpoint: Olerud Molander Ankle Score at 24 months. Started Jan 2017; status: terminated.
02
Conditions
osteochondral lesion of the talus (OLT)
Beyond the preview
Go deeper on NCT02736318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736318.